Back to search
FDAFDA · Food and drugs·Recall number D-0109-2017

PARICALCITOL Capsules, 1 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7656-56.

Published October 26, 2016 · Recall initiated: September 22, 2016

Summary

FDA records drug Class III recall D-0109-2017, published October 26, 2016 and initiated September 22, 2016. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 32,015 bottles; Lot: Lot #: 13013.013A, Exp 04/17. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA
Distributor
Nationwide and Puerto Rico
Lot
Lot #: 13013.013A, Exp 04/17
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PARICALCITOL Capsules, 1 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7656-56. recalled?

Yes. FDA published recall D-0109-2017 on October 26, 2016. Reported hazard: Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.

What should I do if I have this product?

Voluntary: Firm initiated · Letter